Lysophospholipid Signaling Molecules in Fundus Neovascular Diseases
Open Access
- 9 November 2026
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (21) , 10025
Abstract
Fundus neovascular diseases (FNDs) are vision-threatening ocular disorders featuring pathological neovascularization and pose a major global threat to vision health. Their pathogenesis is heterogeneous, involving multiple factors and pathways. Current clinical pharmacotherapies only target a limited range of molecular pathways via narrow mechanisms, leading to frequent suboptimal responses and disease recurrence, which restricts further therapeutic improvement for FNDs. Recent studies demonstrate that lysophospholipid signaling molecules selectively activate multiple cell-surface receptors, including G protein-coupled receptors, triggering multilayered downstream signaling cascades that govern neovascular initiation and progression. Aberrant activation of this endogenous signaling axis may underpin the limited efficacy of existing anti-angiogenic therapies, and its roles in pathological neovascularization have attracted intensive research attention. This review addresses three representative lysophospholipid mediators: lysophosphatidic acid, lysophosphatidylcholine, and sphingosine-1-phosphate. We systematically summarize their metabolic routes, receptor binding profiles, downstream signaling networks, and pro-angiogenic mechanisms. We also discuss the current research status and translational potential of targeting lysophospholipid axes as innovative therapies, aiming to provide theoretical and translational evidence for developing precise pathway-directed interventions.Keywords
Funding Information
- Special projects in key fields of colleges and universities in Guangdong Province (2021ZDZX2031)
- Guangdong Basic and Applied Basic Research Foundation (2022A1515011646)
- Guangdong Basic and Applied Basic Research Fund Provincial Enterprise Joint Fund (2023A1515220249)
- Shantou Medical Health, Science and Technology Project Foundation (220516106492037)
- Shantou University Medical College Research Incubation Program
- Key Research Platforms and Projects of Guangdong Provincial Universities (2022LSYS006)
- Key Research Platforms and Projects of Guangdong Provincial Universities (2023KCXTD013)
This publication has 145 references indexed in Scilit:
- S1PR2 Mediates Smooth Muscle Cell Proliferation and Endothelial Cell Permeability via Akt/mTOR and RhoA/ROCK1 in AtherosclerosisJournal of Biochemical and Molecular Toxicology, 2025
- ApoM-bound S1P acts via endothelial S1PR1 to suppress choroidal neovascularization and vascular leakageAngiogenesis, 2025
- Ang-1 and VEGF: central regulators of angiogenesisMolecular and Cellular Biochemistry, 2024
- Current Knowledge on the Biology of Lysophosphatidylserine as an Emerging Bioactive LipidCell Biochemistry and Biophysics, 2021
- Vitreous metabolomics profiling of proliferative diabetic retinopathyDiabetologia, 2020
- Druggable Lysophospholipid Signaling Pathways2020
- Biosynthetic Enzymes of Membrane Glycerophospholipid Diversity as Therapeutic Targets for Drug Development2020
- Lizhong decoction ameliorates ulcerative colitis in mice via modulating gut microbiota and its metabolitesApplied Microbiology and Biotechnology, 2020
- Phospholipase D and Choline Metabolism2019
- Blockade of sphingosine‐1‐phosphate reduces macrophage influx and retinal and choroidal neovascularizationJournal of Cellular Physiology, 2008